Profile
Brian D.
Blakey is currently the Chief Business Officer at Stealth BioTherapeutics Corp.
and Stealth BioTherapeutics, Inc. He previously worked as a Director at GSK Plc from 1998 to 2004, as Vice President-Marketing at AtheroGenics, Inc. from 2006 to 2010, and as Chief Operations & Strategy Officer at Ogilvy Commonhealth Market Access from 2010 to 2014.
He received a doctorate degree from the University of Florida in 1986.
Brian Blakey active positions
| Companies | Position | Start |
|---|---|---|
| STEALTH BIOTHERAPEUTICS CORP | Corporate Officer/Principal | 2014-01-31 |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Corporate Officer/Principal | 2014-01-31 |
Former positions of Brian Blakey
| Companies | Position | End |
|---|---|---|
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Chief Operating Officer | 2014-01-31 |
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Corporate Officer/Principal | 2010-04-30 |
| GSK PLC | Director/Board Member | 2004-01-31 |
Training of Brian Blakey
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 6 |
|---|---|
AtheroGenics, Inc.
AtheroGenics, Inc. Pharmaceuticals: MajorHealth Technology Develops novel drugs for the treatment of chronic inflammatory diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
University of Florida
University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ogilvy Commonhealth Market Access
Ogilvy Commonhealth Market Access Advertising/Marketing ServicesCommercial Services Provides medical marketing services | Commercial Services |
Stealth BioTherapeutics Corp.
Stealth BioTherapeutics Corp. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops investigational drugs for the treatment of diseases involving mitochondrial dysfunction | Health Technology |
Stealth BioTherapeutics, Inc.
Stealth BioTherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies to treat the mitochondrial dysfunctions and age-related diseases | Health Technology |
- Stock Market
- Insiders
- Brian Blakey
















